Feature Channels: Clinical Trials

Filters close
Released: 6-Apr-2020 3:40 PM EDT
Compound in Fruit Peels Halts Damage and Spurs Neuronal Repair in Multiple Sclerosis
Thomas Jefferson University

Ursolic acid, abundant in fruit peels and some herbs, both prevents and repairs neurons in animal models of multiple sclerosis.

Released: 6-Apr-2020 3:35 PM EDT
BIDMC launches clinical trial to assess common anti-clotting medication for treatment of COVID-19-related respiratory failure
Beth Israel Deaconess Medical Center

A team of physician-scientists at Beth Israel Deaconess Medical Center are now enrolling patients in a clinical trial to evaluate a common anti-clotting drug for the treatment of COVID-19-positive patients with ARDS. The newly launched trial follows a special report the team published in the Journal of Trauma and Acute Care Surgery that suggested the use of a drug called tPA could reduce deaths among patients with ARDS as a complication of COVID-19.

Released: 6-Apr-2020 11:05 AM EDT
Rush Testing Remdesivir as a Potential Treatment for COVID-19
Rush University Medical Center

Rush University Medical Center is participating in a new clinical trial to test the effectiveness of the drug remdesivir in the treatment of coronavirus disease 2019 (COVID-19).

Released: 6-Apr-2020 9:00 AM EDT
NUS researchers uncover hereditary mutation that drives aggressive head and neck, and lung cancers in Asian population
National University of Singapore

New research from the Cancer Science Institute of Singapore at the National University of Singapore revealed a genetic variant in a gene called MET that is responsible for more aggressive growth of head and neck, and lung cancers in Asian populations.

Newswise: UCLA clinical trial tests anti-viral drug remdesivir and other therapies against COVID-19
Released: 3-Apr-2020 4:25 PM EDT
UCLA clinical trial tests anti-viral drug remdesivir and other therapies against COVID-19
University of California, Los Angeles (UCLA), Health Sciences

UCLA Health is one of 75 sites around the globe participating in a clinical trial sponsored by the National Institutes of Health to test the effectiveness of a candidate anti-viral drug against COVID-19.

Newswise: 228393_web.jpg
Released: 3-Apr-2020 2:25 PM EDT
Trial drug can significantly block early stages of COVID-19 in engineered human tissues
University of British Columbia

An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.

Newswise: Rutgers Cancer Institute Offers Clinical Trial Examining Potential Treatment for COVID-19
Released: 3-Apr-2020 1:35 PM EDT
Rutgers Cancer Institute Offers Clinical Trial Examining Potential Treatment for COVID-19
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey, a National Cancer Institute-designated Comprehensive Cancer Center, is offering a clinical trial as a potential treatment for patients diagnosed with the coronavirus (COVID-19). The trial, which is not limited to cancer patients is exploring hydroxychloroquine and azithromycin.

Released: 3-Apr-2020 12:45 PM EDT
Trial for Potential Coronavirus Treatment is Underway at Montefiore and Einstein
Albert Einstein College of Medicine

Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection.

Released: 3-Apr-2020 12:00 PM EDT
Mardil Medical Completes Treatment Of Third Patient In VenTouch™ Device Trial
Mardil Medical

Mardil Medical, Inc., today announced the successful completion of treatment for the third patient in the clinical trial of its improved VenTouch™ device.

Newswise:Video Embedded media-invited-to-ask-questions-covid-19-testing-drug-discovery-infectiousness-and-more-press-conference-april-2-2020
VIDEO
Released: 3-Apr-2020 9:00 AM EDT
TRANSCRIPT AND VIDEO AVAILABLE: Media Invited to Ask Questions - COVID-19 Testing, Drug Discovery, Infectiousness, and more: Press Conference April 2, 2020
Newswise

Media are invited to attend and ask questions at this Virtual Press Conference with a Newswise Live Expert Panel to discuss the COVID-19 crisis.


Showing results

110 of 10

close
1.65867